Veru Announces Preclinical Study Results that Demonstrate Sabizabulin Inhibits Poxviruses
Sabizabulin inhibited the cell release and cell-to-cell spread of poxvirus in a preclinical study Veru…
Sabizabulin inhibited the cell release and cell-to-cell spread of poxvirus in a preclinical study Veru…
Sabizabulin inhibited the cell release and cell-to-cell spread of poxvirus in a preclinical study Veru…
Dr. Redkar to discuss importance of HGF/cMET pathway, which can play critical role in origin…
Dr. Redkar to discuss importance of HGF/cMET pathway, which can play critical role in origin…
BOSTON, April 11, 2023 (GLOBE NEWSWIRE) — Inozyme Pharma, Inc. (Nasdaq: INZY), a clinical- stage…
BOSTON, April 11, 2023 (GLOBE NEWSWIRE) — Inozyme Pharma, Inc. (Nasdaq: INZY), a clinical- stage…
Eight Abstracts Demonstrate Progress of Prelude’s Differentiated Pipeline WILMINGTON, Del., April 11, 2023 (GLOBE NEWSWIRE)…
Eight Abstracts Demonstrate Progress of Prelude’s Differentiated Pipeline WILMINGTON, Del., April 11, 2023 (GLOBE NEWSWIRE)…
MINNEAPOLIS, April 11, 2023 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage…
MINNEAPOLIS, April 11, 2023 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage…
Blue-Zone to install its patented anesthetic capture technology in Respirair manufacturing facility TORONTO, April 11,…
Blue-Zone to install its patented anesthetic capture technology in Respirair manufacturing facility TORONTO, April 11,…
DURHAM, N.C., April 11, 2023 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology…
DURHAM, N.C., April 11, 2023 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology…
STOUGHTON, Mass., April 11, 2023 (GLOBE NEWSWIRE) — Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified…
STOUGHTON, Mass., April 11, 2023 (GLOBE NEWSWIRE) — Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified…
SALT LAKE CITY, April 11, 2023 (GLOBE NEWSWIRE) — Clene Inc. (NASDAQ: CLNN) (along with…
SALT LAKE CITY, April 11, 2023 (GLOBE NEWSWIRE) — Clene Inc. (NASDAQ: CLNN) (along with…
SAN JOSE, Calif., April 11, 2023 (GLOBE NEWSWIRE) — Rani Therapeutics Holdings, Inc. (“Rani Therapeutics”…
SAN JOSE, Calif., April 11, 2023 (GLOBE NEWSWIRE) — Rani Therapeutics Holdings, Inc. (“Rani Therapeutics”…